Milos Miljkovic has an estimated net worth of $7.7 Million. This is based on reported shares in Cartesian Therapeutics, Inc.. Attention insiders: Dive deeper into market movements and stay ahead of ...
Milos Miljkovic, the Chief Medical (TASE: PMCN) Officer of Cartesian Therapeutics, Inc. (NASDAQ:RNAC), has recently sold company shares amounting to $907,532, according to a recent SEC filing. The ...
Milos Miljkovic, Chief Medical (TASE: PMCN) Officer at Cartesian Therapeutics, Inc. (NASDAQ:RNAC), recently sold shares of the company’s common stock valued at $31,541. The transactions occurred on ...
So really quickly on disclosures. So for important disclosures, please see the Morgan Stanley research disclosure website. And if you have any questions, please contact your Morgan Stanley sales ...
Topline data from Phase 2b placebo-controlled study continues to be expected in mid-2024 GAITHERSBURG, Md., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC), (“the Company ...
Cartesian Therapeutics Inc. followed up December’s phase IIb data with more good news regarding Descartes-08, offering 12-month efficacy and safety results that whetted Wall Street’s appetite for the ...
GAITHERSBURG, Md., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC), (“the Company”) a clinical-stage biotechnology company pioneering mRNA cell therapies for autoimmune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback